Latest news
Distinct gut microbiome patterns found in 5 cancer groups and in early-onset cancers
Researchers have discovered distinct gut microbiome patterns in adults 50 or younger with colorectal and breast cancers compared with those diagnosed later in life — one of several findings from an analysis of stool samples from 1,364 patients with cancer across cancer types, stages and treatments.
Scientists overcome key barrier to self-amplifying vaccines
Scientists have overcome a key barrier to self-amplifying vaccines. The innovation could enable protection at lower doses, meaning vaccines could be rolled out further and faster than was previously imaginable. saRNA vaccines hold great promise but are hindered by an inherent flaw which undermines their effectiveness.
AFYREN and Terrial renew their partnership for French-manufactured potash fertilizers
AFYREN and Terrial today announce the renewal of their strategic partnership with the signing of a new multi-year fertilizer supply contract, worth several tens of millions of euros This long-term contract strengthens both companies’ commitment to making French agriculture more sustainable and less dependent on international fertilizer markets.
Gut microbiome emerges as a potential partner in precision cancer therapy
A new editorial examines how the human microbiome may influence cancer development, treatment response and emerging precision-oncology strategies.
The Andes were supposed to stop this cacao killer - they didn’t
Black pod disease destroys up to a quarter of the world’s cacao every year. A study provides the first comprehensive portrait of Phytophthora palmivora’s genetic structure in Colombia. Researchers genotyped and virulence-tested 73 isolates gathered from 48 locations across the country’s three main cacao-growing regions.
Decoding microbial communities: Metax improves taxonomic profiling
Researchers develop a computational tool for accurate identification and abundance estimation of microorganisms in complex samples.
Distinct gut microbiome patterns found in 5 cancer groups and in early-onset cancers
Researchers have discovered distinct gut microbiome patterns in adults 50 or younger with colorectal and breast cancers compared with those diagnosed later in life — one of several findings from an analysis of stool samples from 1,364 patients with cancer across cancer types, stages and treatments.
The Andes were supposed to stop this cacao killer - they didn’t
Black pod disease destroys up to a quarter of the world’s cacao every year. A study provides the first comprehensive portrait of Phytophthora palmivora’s genetic structure in Colombia. Researchers genotyped and virulence-tested 73 isolates gathered from 48 locations across the country’s three main cacao-growing regions.
Study finds community-led dog vaccination could save children’s lives
A community-based approach to vaccinating dogs against rabies could help protect countless children in Africa and other areas from one of the world’s deadliest infectious diseases, according to a new study. The new approach also maintained more consistent vaccination coverage throughout the year.
AFYREN and Terrial renew their partnership for French-manufactured potash fertilizers
AFYREN and Terrial today announce the renewal of their strategic partnership with the signing of a new multi-year fertilizer supply contract, worth several tens of millions of euros This long-term contract strengthens both companies’ commitment to making French agriculture more sustainable and less dependent on international fertilizer markets.
Sharpening an essential tool for biotechnology
Scientists develop a database of validated guide RNAs to improve engineering of microbes for manufacturing applications.
Green hydrogen production and storage using alcohols, iron, and baker’s yeast
A new recyclable system uses baker’s yeast to store H₂ in organic molecules and iron ions to release it when needed - offering a promising route toward more sustainable hydrogen production and storage.
Scientists overcome key barrier to self-amplifying vaccines
Scientists have overcome a key barrier to self-amplifying vaccines. The innovation could enable protection at lower doses, meaning vaccines could be rolled out further and faster than was previously imaginable. saRNA vaccines hold great promise but are hindered by an inherent flaw which undermines their effectiveness.
Wearable nanotech could combat nerve agents
Fungi-inspired nanoparticles could someday provide a new way to help soldiers fight back against deadly nerve agents on the frontline. Scientists developed a nanoparticle-based compound that, when mixed into clothing dyes, could limit the impact of chemicals commonly found in pesticides, insecticides and nerve agents.
New tool closes gap on untapped potential of phages
A new tool to mutate bacteriophages – viruses that infect bacteria – provides a big leap forward in both our understanding of how they function, and our ability to harness their full potential. The new method allows for genome-wide mutagenesis of bacteriophages using CRISPR-Cas technology.
KU secures $5.8 million NIH grant to advance infectious disease research
The National Institutes of Health awarded the University of Kansas $5.8 million for Phase 3 of KU’s Chemical Biology of Infectious Disease center, supporting researchers across KU, KU Medical Center, Kansas State, Wichita State and regional partners in addressing infectious disease and antibiotic resistance.
FAO renews university’s designation as Reference Centre on Antimicrobial Resistance and Aquaculture Biosecurity
The Food and Agriculture Organization of the United Nations is redesignating Mississippi State University as an FAO Reference Centre on Antimicrobial Resistance and Aquaculture Biosecurity.
Could these pills help people with anorexia? A new study aims to find out
A new clinical trial is recruiting people diagnosed with anorexia nervosa as researchers hope to discover if fecal microbiota transplant (FMT) capsules could help better manage this eating disorder.